Monday 16 September 2019

FTSE 100 higher on GlaxoSmithKline merger news

Stocks were also buoyed on news that Brussels and Rome have struck a deal over Italy’s budget.

The FTSE 100 closed 0.96% higher, led by pharmaceutical giant GlaxoSmithKline (Andy Buchanan/PA)
The FTSE 100 closed 0.96% higher, led by pharmaceutical giant GlaxoSmithKline (Andy Buchanan/PA)

By Maryam Cockar, Press Association City Reporter

London’s blue-chip index was in the green on Wednesday, helped by merger news from pharmaceutical giant GlaxoSmithKline and a weaker pound.

The FTSE 100 closed 64.35 points, or 0.96%, higher at 6,765.94.

Fiona Cincotta, senior market analyst at City Index, said Glaxo “led the charge higher on M&A news, with a weaker pound and strength on Wall Street also helping the cause.”

Stocks were also buoyed by news that Brussels and Rome reached an agreement over Italy’s 2019 budget, after being at loggerheads for months.

Italy will now aim for a budget deficit of 2.04% rather than the 2.4% that it had initially planned.

David Madden, market analyst at CMC Markets, said: “There were a lot of fears that the political spat could have triggered another round of the eurozone debt crisis, and those worries have since evaporated”.

Elsewhere, the pound was stronger due to US dollar weakness ahead of the US Federal Reserve’s interest rate decision.

Ms Cincotta said: “Sterling picked itself up from session lows and moved back into the black versus the dollar. However, that was more of a dollar weakness story than a flip in sentiment towards the pound.

“As no-deal Brexit planning is being ramped up in both the UK and the EU, pound traders are increasingly nervous that this could actually all go horribly wrong.”

She added that sterling investors were by no means pricing in a no-deal Brexit, “but nerves are building”.

Sterling was up 0.17% against the US dollar at 1.265, but down 0.37% versus the euro to 1.108 at the London market close.

In corporate news, GlaxoSmithKline agreed a tie-up with US rival Pfizer to merge their consumer healthcare divisions to create a business with combined sales of £9.8 billion.

The deal paves the way for a break-up of Glaxo into two separate UK-based companies – one focused on pharmaceuticals and vaccines, and the other on consumer healthcare – within three years of the completing joint venture.

Glaxo shares closed 54.8p up to 1,503p.

Virgin Atlantic said that it was still considering whether to launch a takeover of regional airline Flybe.

Virgin, part owned by Sir Richard Branson, is thought to be vying with Stobart and British Airways to buy Flybe and is interested in its take-off and landing slots at London’s Heathrow Airport.

Flybe shares rose by 1.6p to 16.8p.

Eleven lenders have been deemed eligible to take a slice of a £775 million Royal Bank of Scotland fund aimed at increasing competition in Britain’s banking sector.

The banks – Monzo, Starling, Arbuthnot, Clydesdale, Co-op Bank, Hampden & Co, Metro Bank, Nationwide, Santander, Handelsbanken and TSB – will be entitled to a share of a £350 million incentivised switching scheme aimed at encouraging small business customers to ditch their RBS account for rivals.

Metro Bank shares were down 22p to 1,696p.

Germany’s DAX was up 0.31% and France’s CAC 40 rose 0.52%.

A barrel of Brent crude, the international benchmark, was trading up 3.14% at 57.71 US dollars (£45.58).

The biggest risers on the FTSE 100 were GlaxoSmithKline up 54.8p to 1,503p, Evraz up 17.2p to 479.2p, Mondi up 46p to 1,630p, and Melrose Industries up 4.5p to 160.35p.

The biggest fallers on the FTSE 100 were Kingfisher down 6p to 214.4p, Randgold Resources down 178p to 6,708p, Royal Mail down 6.8p to 280p, and DS Smith down 5.5p to 296.1p.

PA Media

Today's news headlines, directly to your inbox every morning.

Editors Choice

Also in World News